PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease

Human Molecular Genetics

Volumn 25, Issue 4, 2016, Pages 792-806

  Martín Maestro, Patricia ^a,b   Gargini, Ricardo ^a,b,c   Perry, George ^d   Avila, Jesús ^a,b   García Escudero, Vega ^a,b,e  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; PROTEIN PARK2; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG; MITOCHONDRIAL PROTEIN; PARKIN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; UBIQUITIN PROTEIN LIGASE;

ALZHEIMER DISEASE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; FIBROBLAST; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYSOSOME; MEMBRANE DEPOLARIZATION; MEMBRANE VESICLE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOPHAGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; AGED; BIOSYNTHESIS; BRAIN; CASE CONTROL STUDY; FEMALE; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; PRIMARY CELL CULTURE;

AGED; ALZHEIMER DISEASE; AUTOPHAGY; BRAIN; CASE-CONTROL STUDIES; FEMALE; FIBROBLASTS; HUMANS; LYSOSOMES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL PROTEINS; PRIMARY CELL CULTURE; PROTEIN KINASES; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 85012845547     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv616     Document Type: Article

References (51)

1. Savva, G.M., Wharton, S.B., Ince, P.G., Forster, G., Matthews, F.E. and Brayne, C. (2009) Age, neuropathology, and dementia. N. Engl. J. Med., 360, 2302-2309
2. Price, D.L., Tanzi, R.E., Borchelt, D.R. and Sisodia, S.S. (1998) Alzheimer's disease: genetic studies and transgenic models. Annu. Rev. Genet., 32, 461-493
3. Zhu, X., Perry, G., Smith, M.A. and Wang, X. (2013) Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J. Alzheimers Dis., 33(Suppl. 1), S253-S262
4. Bonda, D.J., Wang, X., Perry, G., Nunomura, A., Tabaton, M., Zhu, X. and Smith, M.A. (2010) Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology, 59, 290-294
5. Reddy, P.H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T.P., Anekonda, V., Shirendeb, U.P., Calkins, M.J., Reddy, A.P., Mao, P. et al. (2012) Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta, 1822, 639-649
6. Wang, X., Su, B., Lee, H.G., Li, X., Perry, G., Smith, M.A. and Zhu, X. (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci., 29, 9090-9103
7. Garcia-Escudero, V., Martin-Maestro, P., Perry, G. and Avila, J. (2013) Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxid. Med. Cell. Longev., 2013, 162152
8. Leuner, K., Schutt, T., Kurz, C., Eckert, S.H., Schiller, C., Occhipinti, A., Mai, S., Jendrach, M., Eckert, G.P., Kruse, S.E. et al. (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid. Redox Signal., 16, 1421-1433
9. Santa-Maria, I., Hernandez, F., Martin, C.P., Avila, J. and Moreno, F.J. (2004) Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry, 43, 2888-2897
10. Taga, M., Mouton-Liger, F., Paquet, C. and Hugon, J. (2011) Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells. FEBS Lett., 585, 1801-1806
11. Bonda, D.J., Castellani, R.J., Zhu, X., Nunomura, A., Lee, H.G., Perry, G. and Smith, M.A. (2011) A novel perspective on tau in Alzheimer's disease. Curr. Alzheimer Res., 8, 639-642
12. Belkacemi, A. and Ramassamy, C. (2012) Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-beta cascade. Free Radic. Biol. Med., 52, 593-600
13. Kopeikina, K.J., Carlson, G.A., Pitstick, R., Ludvigson, A.E., Peters, A., Luebke, J.I., Koffie, R.M., Frosch, M.P., Hyman, B.T. and Spires-Jones, T.L. (2011) Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. Am. J. Pathol., 179, 2071-2082
14. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608
15. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160
16. Lin, W. and Kang, U.J. (2008) Characterization of PINK1 processing, stability, and subcellular localization. J. Neurochem., 106, 464-474
17. Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J., Cookson, M.R. and Youle, R.J. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8, e1000298
18. Bjorkoy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Overvatn, A., Stenmark, H. and Johansen, T. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol., 171, 603-614
19. Shiba-Fukushima, K., Imai, Y., Yoshida, S., Ishihama, Y., Kanao, T., Sato, S. and Hattori, N. (2012) PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci. Rep., 2, 1002
20. Okatsu, K., Oka, T., Iguchi, M., Imamura, K., Kosako, H., Tani, N., Kimura, M., Go, E., Koyano, F., Funayama, M. et al. (2012) PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat. Commun., 3, 1016
21. Geisler, S., Holmstrom, K.M., Skujat, D., Fiesel, F.C., Rothfuss, O.C., Kahle, P.J. and Springer, W. (2010) PINK1/Parkinmediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol., 12, 119-131
22. Gegg, M.E., Cooper, J.M., Chau, K.Y., Rojo, M., Schapira, A.H. and Taanman, J.W. (2010) Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet., 19, 4861-4870
23. Fedorowicz, M.A., de Vries-Schneider, R.L., Rub, C., Becker, D., Huang, Y., Zhou, C., AlessiWolken, D.M., Voos, W., Liu, Y. and Przedborski, S. (2014) Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy. EMBO Rep., 15, 86-93
24. Nixon, R.A., Wegiel, J., Kumar, A., Yu, W.H., Peterhoff, C., Cataldo, A. and Cuervo, A.M. (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol., 64, 113-122
25. Scheper, W., Nijholt, D.A. and Hoozemans, J.J. (2011) The unfolded protein response and proteostasis in Alzheimer disease: preferential activation of autophagy by endoplasmic reticulum stress. Autophagy, 7, 910-911
26. Cuervo, A.M. (2004) Autophagy: in sickness and in health. Trends Cell Biol., 14, 70-77
27. Nixon, R.A. (2005) Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging, 26, 373-382
28. Lee, J.H., Yu, W.H., Kumar, A., Lee, S., Mohan, P.S., Peterhoff, C.M., Wolfe, D.M., Martinez-Vicente, M., Massey, A.C., Sovak, G. et al. (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell, 141, 1146-1158
29. Moreira, P.I., Siedlak, S.L., Wang, X., Santos, M.S., Oliveira, C.R., Tabaton, M., Nunomura, A., Szweda, L.I., Aliev, G., Smith, M.A. et al. (2007) Autophagocytosis ofmitochondria is prominent in Alzheimer disease. J. Neuropathol. Exp. Neurol., 66, 525-532
30. Moreira, P.I., Siedlak, S.L., Wang, X., Santos, M.S., Oliveira, C.R., Tabaton, M., Nunomura, A., Szweda, L.I., Aliev, G., Smith, M.A. et al. (2007) Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy, 3, 614-615
31. Yu, W.H., Kumar, A., Peterhoff, C., Shapiro Kulnane, L., Uchiyama, Y., Lamb, B.T., Cuervo, A.M. and Nixon, R.A. (2004) Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int. J. Biochem. Cell Biol., 36, 2531-2540
32. Cecchi, C., Fiorillo, C., Sorbi, S., Latorraca, S., Nacmias, B., Bagnoli, S., Nassi, P. and Liguri, G. (2002) Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free. Radic. Biol. Med., 33, 1372-1379
33. Citron, M., Vigo-Pelfrey, C., Teplow, D.B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L. and Selkoe, D.J. (1994) Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl Acad. Sci. USA, 91, 11993-11997
34. Martinez-Vicente, M., Talloczy, Z., Wong, E., Tang, G., Koga, H., Kaushik, S., de Vries, R., Arias, E., Harris, S., Sulzer, D. et al. (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci., 13, 567-576
35. Kuo, S.H., Tang, G., Ma, K., Babij, R., Cortes, E., Vonsattel, J.P., Faust, P.L., Sulzer, D. and Louis, E.D. (2012) Macroautophagy abnormality in essential tremor. PLoS ONE, 7, e53040
36. Ozawa, K., Komatsubara, A.T., Nishimura, Y., Sawada, T., Kawafune, H., Tsumoto, H., Tsuji, Y., Zhao, J., Kyotani, Y., Tanaka, T. et al. (2013) S-nitrosylation regulates mitochondrial quality control via activation of parkin. Sci. Rep., 3, 2202
37. Bowman, E.J., Siebers, A. and Altendorf, K. (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl Acad. Sci. USA, 85, 7972-7976
38. Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M. and Tashiro, Y. (1991) Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem., 266, 17707-17712
39. Katsuragi, Y., Ichimura, Y. and Komatsu, M. (2015) p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J., 282, 4672-4678
40. Braak, H. and Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 82, 239-259
41. Hokama, M., Oka, S., Leon, J., Ninomiya, T., Honda, H., Sasaki, K., Iwaki, T., Ohara, T., Sasaki, T., LaFerla, F.M. et al. (2014) Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study. Cereb. Cortex, 24, 2476-2488
42. Wang, X., Wang, W., Li, L., Perry, G., Lee, H.G. and Zhu, X. (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim. Biophys. Acta, 1842, 1240-1247
43. Chu, C.T., Zhu, J. and Dagda, R. (2007) Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death. Autophagy, 3, 663-666
44. Zhu, J.H., Horbinski, C., Guo, F., Watkins, S., Uchiyama, Y. and Chu, C.T. (2007) Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol., 170, 75-86
45. Polgar, L. and Csoma, C. (1987) Dissociation of ionizing groups in the binding cleft inversely controls the endo-and exopeptidase activities of cathepsin B. J. Biol. Chem., 262, 14448-14453
46. Lonskaya, I., Shekoyan, A.R., Hebron, M.L., Desforges, N., Algarzae, N.K. and Moussa, C.E. (2013) Diminished parkin solubility and co-localization with intraneuronal amyloidbeta are associated with autophagic defects in Alzheimer's disease. J. Alzheimers Dis., 33, 231-247
47. Witte, M.E., Bol, J.G., Gerritsen, W.H., van der Valk, P., Drukarch, B., van Horssen, J. and Wilhelmus, M.M. (2009) Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions. Neurobiol. Dis., 36, 445-452
48. Khandelwal, P.J., Herman, A.M., Hoe, H.S., Rebeck, G.W. and Moussa, C.E. (2011) Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models. Hum. Mol. Genet., 20, 2091-2102
49. del Arco, A. and Satrustegui, J. (2004) Identification of a novel human subfamily of mitochondrial carriers with calciumbinding domains. J. Biol. Chem., 279, 24701-24713
50. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63
51. da Costa, C.A., Sunyach, C., Giaime, E., West, A., Corti, O., Brice, A., Safe, S., Abou-Sleiman, P.M., Wood, N.W., Takahashi, H. et al. (2009) Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat. Cell Biol., 11, 1370-1375